EDDRA-Repro: Reproductibility of TM-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the ER

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Completed
CT.gov ID
NCT01743105
Collaborator
(none)
26
1
1
5
5.2

Study Details

Study Description

Brief Summary

The main objective of this study is to evaluate the inter-rater reproducibility of diaphragmatic excursion measures via time-motion-mode ultrasound (evaluation performed on the first measure) in patients experiencing acute respiratory distress emergencies.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Diaphragm excursion measures 1
  • Procedure: Diaphragm excursion measures 2
N/A

Detailed Description

The secondary objectives of this study are:
  • To assess the feasibility of measuring the diaphragmatic excursion in the context of emergency management (ratio of measured patients / included patients).

  • To evaluate the time required for the measurement.

  • To assess the intra-rater reproducibility of measurements of diaphragmatic excursion (comparison of first and second measures).

Study Design

Study Type:
Interventional
Actual Enrollment :
26 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Reproductibility of Time-motion-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the Emergency Room
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Jan 1, 2014
Actual Study Completion Date :
Jan 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study population

The study population consists of patients treated for acute respiratory distress in the emergency department at the Nîmes University Hospital. See inclusion and exclusion criteria. Interventions: Diaphragm excursion measures 1, Diaphragm excursion measures 2

Procedure: Diaphragm excursion measures 1
A first diaphragm ultrasound study will be carried out by investigator 1. A Vivid S6 GE Ultrasound will be used, with a phased array cardiac probe.

Procedure: Diaphragm excursion measures 2
A second diaphragm ultrasound study will be carried out immediately after Ultrasound 1, and by investigator 2. The results are blinded between investigators. A Vivid S6 GE Ultrasound will be used, with a phased array cardiac probe.

Outcome Measures

Primary Outcome Measures

  1. Diaphragmatic excursion, first measure by investigator 1 [Baseline (day 0)]

    in centimeters

  2. Diaphragmatic excursion, first measure by investigator 2 [Baseline (day 0)]

    in centimeters

Secondary Outcome Measures

  1. Time necessary to measure diaphragm movement amplitude (minutes) [Baseline (day 0)]

  2. Feasibility (yes/no) [Baseline (day 0)]

    We were able to perform the required measurements (yes/no)

  3. Diaphragmatic excursion, second measure by investigator 1 [Baseline (day 0)]

    (centimeters)

  4. Diaphragmatic excursion, second measure by investigator 2 [Baseline (day 0)]

    (centimeters)

Other Outcome Measures

  1. Age [Baseline (day 0)]

  2. Sexe [Baseline (day 0)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient must have given his/her informed and signed consent

  • The patient must be insured or beneficiary of a health insurance plan

  • The patient has acute respiratory distress defined by a respiratory rate > 25, and / or signs of struggle and hypoxia, oxygen saturation (SpO2) <90% and / or pH <7.35 and carbon dioxide partial pressure (pCO2) > 6 kPa (45 mm Hg)

  • The patient breathes spontaneously (no respirator)

Exclusion Criteria:
  • The patient is participating in another study

  • The patient is in an exclusion period determined by a previous study

  • The patient is under judicial protection, under tutorship or curatorship

  • The patient or his/her representative refuses to sign the consent

  • It is impossible to correctly inform the patient, or to correctly inform his/her representative

  • The patient is pregnant, parturient, or breastfeeding

  • The patient has a neurological or neuromuscular disease that modifies diaphragm function/movement; this does not include cases of decompensation (polyradiculoneuropathy, Lou Gehrig's disease, Myasthenia ...).

  • Patient admitted with respiratory support treatment in progress

  • Patient admitted with respiratory failure requiring immediate implementation of mechanical ventilation, thus preventing ultrasound measurements

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09 Gard France 30029

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nīmes

Investigators

  • Principal Investigator: Xavier Bobbia, MD, Centre Hospitalier Universitaire de Nîmes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier:
NCT01743105
Other Study ID Numbers:
  • LOCAL/2012/XBAC-01
  • 2012-A01094-39
  • Bobbia EDDRA Repro
First Posted:
Dec 6, 2012
Last Update Posted:
Mar 26, 2015
Last Verified:
Mar 1, 2015
Keywords provided by Centre Hospitalier Universitaire de Nīmes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 26, 2015